News

Supreme Court Limits Trustee Avoidance Powers in U.S. v. Miller - Section 106(a) Doesn’t Waive Sovereign Immunity for State-Law-Based Section 544(b) Claims

By EsqSocial Corporation 17/04/25

Section 106(a) Doesn’t Waive Sovereign Immunity for State-Law-Based Section 544(b) Claims - The U.S. Supreme Court has significantly curtailed bankruptcy trustees’ powers in United States v. Miller, 145 S. Ct. 839 (2025).

Legal Developments in Construction Law April 2025 New

By EsqSocial Corporation 17/04/25

1. AND "WITHOUT PREJUDICE" PROTECTION FROM DISCLOSURE APPLIES WHEN? Without prejudice privilege is a legal rule protecting genuine negotiation discussions from disclosure, the object being to encourage negotiations that may lead to a commercial settlement....

Compliance Notes, Vol. 6, Issue 8 - April 2025

By EsqSocial Corporation 17/04/25

RECENT LOBBYING, ETHICS & CAMPAIGN FINANCE UPDATES - Campaign Finance & Lobbying Compliance - Hawaii: Hawaii lawmakers are working to outlaw political donations from people who win government contracts....
By: Nossaman LLP

To Some, It’s About ERISA—to Everyone, It’s About Not Having to Plead Affirmative Defenses - SCOTUS Today

By EsqSocial Corporation 17/04/25

Notwithstanding its mounting backlog, the U.S. Supreme Court resolved only one case today, an unsurprising unanimous decision in Cunningham v. Cornell University....
By: Epstein Becker & Green

Court Strikes Down Nursing Home Minimum Staffing Rule

By EsqSocial Corporation 17/04/25

On April 7, 2025, the United States District Court for the Northern District of Texas ruled in favor of the American Health Care Association (“AHCA”) in its lawsuit against Health and Human Services (“HHS”) Secretary Robert F. Kennedy Jr.

Department of Commerce Announces Section 232 Pharmaceutical Investigation

By EsqSocial Corporation 17/04/25

The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve as a precursor to imposing tariffs on the pharmaceuticals sector.

Commerce Seeks Comments on Section 232 Pharmaceutical Investigation

By EsqSocial Corporation 17/04/25

Yesterday, April 16, 2025, the Bureau of Industry and Security (BIS), a bureau within the U.S. Department of Commerce, published a “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients.”...

Keeping Track of the Trump Administration Tariffs

By EsqSocial Corporation 17/04/25

To keep track of the Trump Administration tariff plans and actions requires vigilance. The difficulty in monitoring daily tariff actions and the impact is a challenge to all trade compliance officers.

CPPA Announces Enforcement Action Against Automaker

By EsqSocial Corporation 17/04/25

On 12 March 2025, the California Privacy Protection Agency (CPPA) settled with an automaker that allegedly violated various aspects of the California Consumer Privacy Act (CCPA).

Trademark Opposition Proceedings in Canada: Proposed Changes Now in Place

By EsqSocial Corporation 17/04/25

In July 2024, I discussed proposed changes to trademark proceedings in Canada. Following a public consultation period, revised Regulations came into force on April 1, 2024 that incorporate those proposed changes.

Pages